retail news in context, analysis with attitude

Reuters reports that AquaBounty Technologies, the company that has developed genetically engineered salmon "with the potential to grow to market size in half the time of conventional salmon," is predicting that it will get regulatory approval from the US Food and Drug Administration (FDA) before the end of the year.

"There have been no new legal issues, no new regulatory issues, no new environmental issues raised," says AquaBounty Technologies CEO Ronald Stotish.

According to the story, the FDA "is due to close a public comment period on Friday and will then likely take 30 to 60 days to review the comments, which include heavy opposition from consumer and environmental groups," which maintain that the salmon represents a "dangerous experiment."

Even if the FDA approves the sale of the GM salmon for human consumption, it is seen as likely that lawsuits could still prevent the product from making it to market anytime soon.
KC's View:
My problem is not with them selling it. It is with not labeling it as genetically modified.